M VR, Gnk G, B B, Jagadeesan R, M R PK. Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration: Risk assessment of CGT and PC Exclusivity drugs. AMM [Internet]. 2022 Mar. 9 [cited 2026 Feb. 10];68(1). Available from: https://ojs.actamedicamarisiensis.ro/index.php/amm/article/view/126